Incretide

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIncretide
Drug Alias Nameglucose-dependent insulinotropic polypeptide analog (Diabetica)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSyndromeObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiabetica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiabetica Ltd
Active IndicationsN/A
Inactive IndicationsSyndromeObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A